AB 2640
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| Astrazeneca Pharmaceuticals, LP | Lobbied on it | Astrazeneca Pharmaceuticals, LP named AB 2640 in 3 lobbying reports. | 3 reports |
| Association of Northern California Oncologists | Lobbied on it | Association of Northern California Oncologists named AB 2640 in 2 lobbying reports. | 2 reports |
| Abbvie | Lobbied on it | Abbvie named AB 2640 in 1 lobbying report. | 1 report |
| Biotechnology Innovation Organization | Lobbied on it | Biotechnology Innovation Organization named AB 2640 in 1 lobbying report. | 1 report |
| California Clinical Laboratory Association | Lobbied on it | California Clinical Laboratory Association named AB 2640 in 1 lobbying report. | 1 report |
| California Life Sciences | Lobbied on it | California Life Sciences named AB 2640 in 1 lobbying report. | 1 report |
| City of Hope National Medical Center | Lobbied on it | City of Hope National Medical Center named AB 2640 in 1 lobbying report. | 1 report |
| Medical Oncology Association of Southern California | Lobbied on it | Medical Oncology Association of Southern California named AB 2640 in 1 lobbying report. | 1 report |
| Health care coverage: genetic biomarker testing. | Source records | AB 2640 has an explicit source reference to Health care coverage: genetic biomarker testing.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…